Your search starts here:
JAX-CKB can help increase clinician confidence in completeness and accuracy of the information related to the patient’s tumor genomic profile.
For translational and clinical researchers, JAX-CKB provides thousands of literature citations, FDA drug labels, and clinical trials relative to a tumor’s genomic mutation or profile, resulting in a clear and up-to-date picture of discoveries and active developments for a variety of biomarkers.
Current data includes:
- Gene and variant descriptions
- Drug indication status
- Clinical Trials by indication
- Treatment approaches
- Efficacy evidence supporting response to treatment approaches by indication
- Resistance evidence supporting resistance to treatments by indication
